{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:34:04Z","timestamp":1793565244351,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jhepr.2020.100171","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T19:17:37Z","timestamp":1597519057000},"page":"100171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Pegah","family":"Golabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rati","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"de Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2020.100171_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cger.2011.03.003","article-title":"Sarcopenia: origins and clinical relevance","volume":"27","author":"Rosenberg","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jhepr.2020.100171_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2016.08.002","article-title":"Pathogenesis and management of sarcopenia","volume":"33","author":"Dhillon","year":"2017","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jhepr.2020.100171_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.jhepr.2020.100171_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13539-010-0014-2","article-title":"An overview of sarcopenia: facts and numbers on prevalence and clinical impact","volume":"1","author":"von Haehling","year":"2010","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jhepr.2020.100171_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40200-017-0302-x","article-title":"Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies","volume":"16","author":"Shafiee","year":"2017","journal-title":"J\u00a0Diabetes Metab Disord"},{"key":"10.1016\/j.jhepr.2020.100171_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/obr.12776","article-title":"Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?","volume":"20","author":"De Fr\u00e9","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.jhepr.2020.100171_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100171_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7570\/jomes.2019.28.2.129","article-title":"Sarcopenia is significantly associated with presence and severity of nonalcoholic fatty liver disease","volume":"28","author":"Chung","year":"2019","journal-title":"J\u00a0Obes Metab Syndr"},{"key":"10.1016\/j.jhepr.2020.100171_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.02.051","article-title":"Sarcopenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008\u20132011)","volume":"63","author":"Lee","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100171_bib10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100171_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.clnu.2017.11.021","article-title":"Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): the importance of sarcopenia definition","volume":"38","author":"Peng","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhepr.2020.100171_bib12","first-page":"1","article-title":"National health and nutrition examination survey: sample design, 2011-2014","author":"Johnson","year":"2014","journal-title":"Vital Health Stat 2"},{"key":"10.1016\/j.jhepr.2020.100171_bib14","series-title":"NCHS 2011 Linked Public Use Data Dictionary","year":"2015"},{"key":"10.1016\/j.jhepr.2020.100171_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100171_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100171_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jhepr.2020.100171_bib21","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"63","author":"Goff","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2020.100171_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/met.2018.0105","article-title":"Prevalence of optimal metabolic health in American adults: national health and nutrition examination survey 2009-2016","volume":"17","author":"Ara\u00fajo","year":"2019","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jhepr.2020.100171_bib23","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2020.100171_bib24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhepr.2020.100171_bib25","first-page":"552","article-title":"National Cholesterol Education Program Adult Treatment Panel III versus International Diabetic Federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease?","volume":"3","author":"Rezaianzadeh","year":"2012","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.jhepr.2020.100171_bib26","series-title":"Taylor Series Methods. Introduction to Variance Estimation","author":"Wolter","year":"2007"},{"key":"10.1016\/j.jhepr.2020.100171_bib27","unstructured":"Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, et\u00a0al. National Health and Nutrition Examination Survey: analytic guidelines, 1999-2010. Vital Health Stat 2 2013;(161):1\u201324."},{"key":"10.1016\/j.jhepr.2020.100171_bib28","series-title":"Survival Analysis Using the SAS System: A Practical Guide","author":"Allison","year":"1995"},{"key":"10.1016\/j.jhepr.2020.100171_bib29","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"2004"},{"key":"10.1016\/j.jhepr.2020.100171_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global\u00a0epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100171_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnagi.2014.00192","article-title":"Sarcopenia and physical frailty: two sides of the same coin","volume":"6","author":"Cesari","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jhepr.2020.100171_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","article-title":"Sarcopenia and mortality among a population-based sample of community-dwelling older adults","volume":"7","author":"Brown","year":"2016","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jhepr.2020.100171_bib33","doi-asserted-by":"crossref","first-page":"e10805","DOI":"10.1371\/journal.pone.0010805","article-title":"Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III","volume":"5","author":"Srikanthan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100171_bib34","first-page":"693","article-title":"Sarcopenic obesity: definition, cause and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jhepr.2020.100171_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ijo.2009.130","article-title":"Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study","volume":"33","author":"Kim","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jhepr.2020.100171_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/sjg.SJG_237_17","article-title":"Sarcopenia and risk of nonalcoholic fatty liver disease: a meta-analysis","volume":"24","author":"Wijarnpreecha","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100171_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhep.2016.09.023","article-title":"The association between sarcopenia and non-alcoholic fatty liver disease","volume":"66","author":"Hu","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100171_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-015-3751-0","article-title":"Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis","volume":"59","author":"Abdulla","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2020.100171_bib39","doi-asserted-by":"crossref","first-page":"6297651","DOI":"10.1155\/2017\/6297651","article-title":"The common mechanisms of sarcopenia and NAFLD","volume":"2017","author":"Zhai","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2020.100171_bib40","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12603-011-0366-0","article-title":"Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction","volume":"15","author":"Abbatecola","year":"2011","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.jhepr.2020.100171_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2015.10.031","article-title":"The association between sarcopenia and non-alcoholic fatty liver disease: potential pitfalls in non-invasive prediction models","volume":"64","author":"Kim","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100171_bib42","doi-asserted-by":"crossref","first-page":"5016091","DOI":"10.1155\/2018\/5016091","article-title":"The relationship between NAFLD and sarcopenia in elderly patients","volume":"2018","author":"Zhai","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100171_bib43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1507\/endocrj.EJ16-0124","article-title":"The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes","volume":"63","author":"Hashimoto","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.jhepr.2020.100171_bib44","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100171_bib45","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.29003","article-title":"A\u00a0practical approach to nutritional screening and assessment in cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100171_bib46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.24958","article-title":"Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list","volume":"24","author":"Duarte-Rojo","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2020.100171_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-018-0776-0","article-title":"Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100171_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100171_bib49","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100171_bib50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920301051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920301051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:05Z","timestamp":1762899965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920301051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2589555920301051"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100171","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100171"}}